| Bioactivity | Mead ethanolamide is an endogenous cannabinoid receptor agonist with Kd values of 753 nM and 1810 nM against CB1 and CB2, respectively[1]. |
| Invitro | Mead ethanolamide inhibits cAMP accumulation in CHO-hCB1 and CHO-hCB2 cells with IC50s of 431 nM and 156 nM, respectively[1].Mead ethanolamide (1-1000 nM) inhibits N-type calcium currents in a concentration-dependent manner. Inhibition was halfmaximal at a Mead ethanolamide concentration of 124 ± 19 nM[1]. |
| Name | Mead ethanolamide |
| CAS | 169232-04-6 |
| Formula | C22H39NO2 |
| Molar Mass | 349.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Mead ethanolamide
CAS: 169232-04-6 F: C22H39NO2 W: 349.55
Mead ethanolamide is an endogenous cannabinoid receptor agonist with Kd values of 753 nM and 1810 nM against CB1 and CB2
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.